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Abstract.  The integrins have recently been implicated 
in signal transduction. A  likely mediator of integrin sig- 
naling is focal adhesion kinase (pp125 FAK or FAK), a 
structurally distinct protein tyrosine kinase that be- 
comes enzymatically activated upon engagement of in- 
tegrins with their ligands. A second candidate signaling 
molecule is paxillin, a focal adhesion associated, cyto- 
skeletal protein that coordinately becomes phosphory- 
lated on tyrosine upon activation of pp125 FAK. Paxillin 
physically complexes with two protein tyrosine kinases, 
pp60  sr~ and Csk (COOH-terminal src kinase), and the 
oncoprotein p47gag-crk, each of which could function as 
part of a paxillin signaling complex. Using an in vitro 
assay we have established that the cytoplasmic domain 
of the 131 integrin can bind to paxillin and pp125 zAK 
from chicken embryo cell lysates. The NH2-terminal , 
noncatalytic domain of pp125 FAK can bind directly to 
the cytoplasmic tail of 131 and recognizes integrin se- 
quences distinct from those involved in binding to 
a-actinin. Paxillin binding is independent of pp125 FAK 
binding despite the fact that both bind to the same re- 
gion of 131 . These results demonstrate that the cytoplas- 
mic domain of the 13 subunits of integrins contain bind- 
ing sites for both signaling molecules and structural 
proteins suggesting that integrins can coordinate the 
generation of cytoplasmic signals in addition to their 
role in anchoring components of the cytoskeleton. 
T 
HE  integrins  are  heterodimeric,  transmembrane 
proteins that simultaneously bind to proteins of the 
extracellular matrix and to components of the actin 
cytoskeleton (reviewed in Albelda and Buck, 1990; Sastry 
and Horwitz, 1993).  In addition to the obvious structural 
role fulfilled by these proteins, emerging evidence has im- 
plicated the  integrins  as  active transducers  of molecular 
signals (reviewed in Hynes, 1992; Schwartz, 1992; Jutiano 
and  Haskill,  1993). Attachment of the  integrins to their 
ligands  triggers cytoplasmic changes including elevations 
of [Ca2+]i (Richter et al., 1990; Jaconi et al., 1991; Pelletier 
et  al.,  1992;  Schwartz,  1993)  and  pHi  (Schwartz  et  al., 
1991a,b), the phosphorylation of cellular proteins on ty- 
rosine (Guan et al., 1991; Kornberg et al., 1991) and the 
activation of at least one protein tyrosine kinase (PTK),  1 
pp125 FAK (Guan and Shalloway, 1992; Lipfert et al., 1992). 
pp125 FAK (focal adhesion kinase) is a unique PTK bearing 
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a  central catalytic domain flanked by large  noncatalytic 
NH2- and COOH-termini (Hanks et al.,  1992; Schaller et 
al., 1992). pp125 FAK colocalizes with the integrins to cellu- 
lar  focal  adhesions  (Hanks  et  al.,  1992;  Schaller  et  al., 
1992), structures that form at regions of close contact with 
the extracellular matrix (Burridge et al., 1988; Turner and 
Burridge, 1991).  Amino acid sequences located near the 
COOH terminus of pp125 FAK target it to focal adhesions 
(Hildebrand et al., 1993). Sequences that extensively over- 
lap with this targeting region also mediate binding to the 
cytoskeletal  protein  paxillin  (Hildebrand  et  al.,  1995). 
pp60  src  and  src-related  PTKs  physically  associate  with 
pp125 FAK through interactions mediated by the SH2 do- 
mains within the src-related PTKs and the major site of 
autophosphorylation of pp125 FAK, tyrosine  397 (Cobb et al., 
1993;  Schaller  et  al.,  1994).  The recruitment  of src-like 
PTKs into pp125 FAK containing complexes may be a mech- 
anism for amplification and/or diversification of the mo- 
lecular signals that trigger the activation of pp125  FAK. 
The integrins play a central role in the formation of fo- 
cal adhesions. Based upon in vitro binding data, they ap- 
pear to provide anchorage for cytoskeletal proteins that in 
turn bind to actin filaments. Current models propose that 
the integrins are linked to actin via two sets of protein- 
protein interactions. Integrins bind to ct-actinin (Otey et 
al.,  1990), which  binds  directly to  actin  (Bennett et  al., 
1984).  Integrins  also  bind to talin  (Horwitz et  al.,  1986; 
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Mangeat, 1984). Vinculin in turn, complexes with a-actinin 
(Belkin and  Koteliansky,  1987; Wachsstock et al.,  1987) 
and  tensin,  each of which  exhibits actin-binding  activity 
(Bennett et al., 1984; Lo et al., 1994).  Thus, several focal 
adhesion-associated proteins have been proposed to func- 
tion, at least in part, in tethering actin to the integrin at 
sites of focal adhesion formation. Several other proteins 
localize to focal adhesions  including  paxillin,  a  vinculin 
binding protein (Turner et al., 1990), and zyxin, an c~-acti- 
nin binding protein (Crawford et al.,  1992).  In contrast to 
zyxin whose function is presently obscure, paxillin exhibits 
a number of interesting properties that suggests it might 
function in  signaling.  It  becomes phosphorylated on  ty- 
rosine  when  fibroblasts  spread  on  ECM  proteins  (Bur- 
ridge  et  al.,  1992)  and  in  cells  transformed  by  pp60  src 
(Glenney and Zokas, 1989; Schaller and Parsons, 1995; un- 
published observations). Furthermore, paxillin can bind to 
several proteins involved in oncogenic transformation and/ 
or  cytoplasmic signaling  including  pp60  src  (Weng  et  al., 
1993),  Csk (COOH-terminal src kinase; a PTK that phos- 
phorylates and negatively regulates the activity of pp60  ~-sr~) 
(Sabe et at., 1994) and the adaptor protein p47g  "g~k (Birge 
et al., 1993). Csk and p47  g~g-crk bind to tyrosine-phosphory- 
lated motifs on paxillin via their src-homology 2 (SH2) do- 
mains, whereas pp60  ~rc binds through its src-homology 3 
(SH3) domain. Thus paxillin exhibits a number of features 
suggesting that it functions in signaling. 
The integrins themselves have no enzymatic activity and 
therefore must rely upon interactions with accessory pro- 
teins for the generation of cytoplasmic signals.  One such 
candidate  signaling  molecule is  the  PTK, pp125  FAR. We 
have  considered several mechanisms  by which  the  inte- 
grins  might  regulate  the  activity of pp125  yAK and  have 
tested the hypothesis that pp125  FAR is an integrin binding 
protein. Using an in vitro assay we have established that 
the membrane proximal region of the cytoplasmic domain 
of the 131 integrin subunit binds directly to the NH2-termi- 
nal region of pp125  FAK. The same fragment of the 131 sub- 
unit can associate with paxillin in cell lysates, although it is 
as yet unknown whether this interaction is direct. These 
data indicate that the  cytoplasmic domain of the  13 sub- 
units may serve as a docking site for signaling molecules, 
in addition to binding to structural proteins such as talin 
and c~-actinin, and is intimately involved in the generation 
of intracellular signals following stimulation with ligand. 
Materials and Methods 
Peptide Binding Experiments 
The synthetic peptides 131 (CKLLMIIHDRREFAKFEKEKMNAKWDT- 
GENPIYKSAVTI'VVNPKYEGK), 133 (CKLLITIHDRKEFAKFEEERA- 
RAKWDTANNPLYKEATSTFTNITYRGT),  SP1  (CKLLMIIHDRR- 
EFA),  SP2  (CFAKFEKEKMNAKW),  SP3  (CKWDTGENPIYKSA), 
and  SP4  (CAVTTVVNPKYEGK)  were  synthesized  by  the  Protein 
Chemistry Laboratory at the University of North Carolina at Chapel Hill. 
SP1 was also purchased from Quality Controlled Biochemicals (Hopkin- 
ton, MA) as was peptide SP1AA (CKLLMIIHARRAFA). The 132 peptide 
(CKALIHLSDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNP- 
KFAES)  was  a  gift  of  Dr.  Fredrick  Pavalko.  Mass spectrometry and 
amino acid analysis was carried out to confirm the sequence and purity of 
individual peptides. Each was coupled via its NH2-terminal cysteine resi- 
due to thiolpropyI-Sepharose beads as described (Otey et al., 1990)  and 
the extent of coupling was determined by monitoring the release of the re- 
action  product,  2-thiopyridone  (absorption  coefficient  =  8.08  ×  103 
M  l-cm  1 at 343 nm) (Stuchbury et al., 1975).  After coupling, the beads 
were incubated with 2-mercaptoethanol to inactivate any unreacted bind- 
ing sites on the beads, then extensively washed and blocked with BSA. 
Chicken embryo (CE) cells or CE ceils infected with avian retroviruses 
engineered to express either wild type pp125  vAr~ or one of a  number of 
variants (Hildebrand  et al.,  1993;  Schaller et al.,  1993)  were  lysed with 
modified radioimmunoprecipitation assay buffer as described (Kanner et 
al., 1989). Lysates were diluted to 500 txg/ml and ~500 Ixg of total protein 
was incubated with peptide coated sepharose beads at 4°C for 1-2 h with 
constant rocking. For competition experiments 3 or 6 mM free 131 peptide 
was incubated with the lysate for 1 h before the addition of the 131-beads. 
For experiments utilizing in vitro translated polypeptides or proteins puri- 
fied from Escherichia  coli, the sample was diluted in modified radioimmu- 
noprecipitation assay buffer containing 1 mg/ml BSA before addition of 
the beads. The beads were collected at 120 g for 2 min, washed 5-6 times 
with Tris-buffered saline (10 mM Tris, pH 8.0,  150 mM NaC1) and bound 
proteins eluted with  Laemmli sample buffer (Laemmli,  1970).  Eluates 
were analyzed by SDS-PAGE and Western blotting as described (Kanner 
et al., 1990)  using the anti-pp125  FAK mAb 2A7 (Kanner et al., 1990)  or 
polyclonal serum BC3 (Schaller et al., 1992).  Western blotting was also 
carried  out using the anti-cortactin mAbs 1H3 or 4Fll  (Kanner et  al., 
1990), the anti-vinculin mAb Vin 11-5 (Sigma Chem. Co., St. Louis, MO), 
an anti--a-actinin serum (a gift of Dr. Keith Burridge, University of North 
Carolina,  Chapel  Hill,  NC),  an anti-paxillin mAb (a  gift of  Dr.  C.  E. 
Turner, SUNY Health Science Center, Syracuse, NY or purchased from 
Transducfion Laboratories,  Lexington, KY) or mAb KT3 which recog- 
nizes an epitope tag on certain pp125  FAn constructs (Schaller et al., 1993). 
Primary  antibodies  in  Western  blots  were  visualized  using  enhanced 
chemiluminescence (Amersham Corp., Arlington Heights, IL). Radiola- 
beled samples were detected by autoradiography or by fluorography using 
En3hance (Dupont, Boston, MA). 
Expression of FAK in E. coil 
Fragments of the FAK cDNA were subcloned into the vector pGex2TK 
(Pharmacia, Piscataway, NJ).  Glutathione-S-Transferase fusion proteins 
containing pp125 FAK residues 31-376 (nterm) or 765-1052 (cterm) were 
expressed in E. coli and purified using glutathione sepharose beads (Smith 
and Johnson, 1988). The protein kinase A site located at the junction be- 
tween the glutathione-S-transferase (GST) and FAK sequences was phos- 
phorylated in vitro (Kaelin et al., 1992),  and the FAK polypeptides were 
cleaved from the GST protein with thrombin (Smith and Johnson, 1988). 
The nterm and cterm polypeptides were then analyzed for binding as de- 
scribed above. 
Immunoprecipitation 
In clearing experiments, ~500 ~.g of tysate was incubated with either mAb 
2A7 or a mAb that recognizes paxillin and the immune complexes precip- 
itated with goat anti-mouse antibodies conjugated to agarose (Sigma). An 
aliquot of the cleared lysate was removed as loading control and the re- 
mainder diluted to 1 ml with radioimmunoprecipitation assay buffer, incu- 
bated with 131 beads for 1 h, washed, and analyzed as above. 
Results 
To test the hypothesis that pp125  yAK can physically inter- 
act with the cytoplasmic domains of integrins, an in vitro 
binding  assay  was  developed using  a  synthetic peptide, 
identical in sequence to the complete cytoplasmic domain 
of the 13t integrin subunit, coupled to thiopropyl-sepharose 
beads.  The beads  were  incubated with  lysates prepared 
from either CE cells or CE cells overexpressing pp125 FAR, 
recovered by centrifugation and extensively washed. Pro- 
teins bound to the beads were analyzed by Western blot- 
ting (Fig. 1 A). Based upon the intensities of the signals in 
the loading control (lane 1) and the sample bound to the 
beads, it can be estimated that ~10%  of the pp125 FAR in 
the lysates bound to the 131 beads. Binding was not simply 
due to nonspecific trapping of proteins since far less than 
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the  [31  beads  (Fig.  1  A).  In  fact  a  similar  proportion  of 
et-actinin  (~10%),  a  known  integrin  binding  protein,  was 
also retained on the  [31 beads  (Fig.  1 A). Preincubation  of 
the lysate with free peptide effectively inhibited binding of 
pp125 FAK to the  [3~ peptide  coated  beads,  indicating  that 
pp125 yak bound specifically to the peptide sequence  (Fig. 
1  B).  A  number  of other  cytoskeletal  proteins  were  also 
examined to determine the specificity of this assay. CE cell 
lysates (expressing only endogenous pp125 FAK) were incu- 
bated  with  beads  and  binding  of  specific  proteins  was 
monitored by Western blotting. Vinculin exhibited a small 
amount of binding to [~l-beads (~1-2%  of the vinculin  in 
the  lysate),  however,  this  binding  was  significantly  less 
than the binding  activity of c~-actinin (at least 10%  of the 
a-actinin  in  the  lysate)  (Fig.  1  C).  Paxillin,  in  contrast, 
bound  very  efficiently  to  the  integrin  beads  (Fig.  1  C). 
Therefore this assay detected  the selective binding of sev- 
eral  cytoskeletal  proteins,  including  a  known  integrin 
binding protein,  to a  peptide  modeled  upon  the  cytoplas- 
mic domain of the [31 integrin. 
The  binding  of cytoskeletal  proteins  to  the  [31  peptide 
sequence was further characterized using four shorter pep- 
tides, each corresponding to approximately one-quarter of 
the full- length [31 peptide (Otey et al., 1993). Incubation of 
each of the peptides, coupled to beads, with cell lysates re- 
vealed  that  pp125 FAK  bound  to  beads  coupled  to  short 
peptide 1 (SP1) but bound poorly to each of the other pep- 
tides,  SP2-SP4  (Fig.  2  A).  Similarly,  paxillin  bound  effi- 
Figure 2.  pp125 vA~ and paxillin bind to SP1. Approximately 500 
Ixg of CE cell lysate was incubated  with beads coupled to SP1 
(lane 2), SP2 (lane 3), SP3  (lane 4), or SP4 (lane 5), the beads 
washed and bound proteins subjected to Western blotting to de- 
tect pp125 yAK (A), c~-actinin (B), paxillin (C) or FAK or FRNK 
(D). Lane 1 contains 50 tzg of lysate as a loading control. 
ciently only to SP1  (Fig. 2  C). pp125 yAK and paxillin bind- 
ing contrasts with the binding activity exhibited by a-actinin. 
As  shown  previously  (Otey  et  al.,  1993),  a-aetinin  binds 
predominantly  to  SP2  (Fig,  2  B).  The  autonomously 
expressed  COOH-terminal  domain  of  pp125  FAK, FAK- 
related  nonkinase  (FRNK),  failed  to bind  to  SP1  (Fig.  2 
D). These results further underscored the specificity of the 
pp125FAK-[31  interaction  and  indicated  that  the  pp125  FAK 
and paxillin binding  sites resided  in the  membrane proxi- 
mal 13 residues of the [31 cytoplasmic domain. 
The sequences of the cytoplasmic domains of the differ- 
ent  [3  integrin  subunits  are  quite  divergent  (Sastry  and 
Horwitz,  1993).  This diversity was exploited to further de- 
fine residues  required  for binding  to pp125 vA~. pp125 FAK 
was found  to bind  not  only to a  synthetic  [3a peptide  but 
also to synthetic peptides identical in sequence to the cyto- 
Figure 1. pp125 yAK and paxillin complex with [31 peptide. (A) Ap~ 
proximately  500  Ixg  of  lysate  from  CE  cells  overexpressing 
pp125  yAK were incubated with [31 beads, washed, and subjected to 
Western blotting analysis (lane 2). A loading control, 10% or 50 
Ixg of lysate was analyzed in parallel (lane 1). Blots were probed 
with  BC3  (top)  to  detect pp125 FAK, a  polyclonal antiserum  di- 
rected against c~-actinin (middle) or mAb 4F11 to detect cortactin 
(bottom). (B) pp125 yAK was bound to [31 beads and analyzed as in 
A (lanes 1 and 2). Alternatively, lysates were preincubated with 3 
(lane 3) or 6 mM (lane 4) free [31 peptide prior to incubation with 
[31 beads. (C) Approximately 500  ixg of CE cell lysate was incu- 
bated with 131 beads and the bound proteins analyzed by Western 
blotting  (lane 2).  50  Ixg of lysate was run  as  a  loading control 
(lane 1). The blots were probed with mAb Vin 11-5 to detect vin- 
culin (top), antiserum directed against a-actinin (middle) or mAb 
directed against paxillin (bottom). 
Figure 3. pp125 FAK binds to [32, 132, and ~  integrin peptides. (A) 
Lysate from CE cells expressing exogenous pp125  FAK was incu- 
bated with 13a beads (lane 2), 132 beads (lane 3), or 133 beads (lane 
4) and the bound proteins eluted, subjected to SDS-PAGE and 
Western blotted to detect pp125 FAK. Loading control is shown in 
lane 1.  (B) Sequence  comparison of the  131, [~2, and  133 integrin 
peptides within the region corresponding to SP1. A consensus se- 
quence is shown in bold. Arrows denote highly conserved acidic 
residues. (C) Lysate from CE cells expressing exogenous pp125  yAK 
was incubated with SP1 beads (lane 2) or SPIAA beads (lane 3) 
and the bound proteins blotted for pp125  FA~. Loading control is 
in lane 1. 
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A). The 131 and 133 sequences are highly conserved through- 
out the membrane proximal region of the cytoplasmic do- 
main  and  therefore  binding  to each was anticipated.  The 
132 integrin sequence is strikingly different.  Comparison of 
the sequences  of 13~ and  132 reveals a  highly conserved  as- 
partic acid and glutamic acid residue within the membrane 
proximal region of the cytoplasmic domain and these resi- 
dues are highly conserved in other integrins as well (Fig. 3 
B; Sastry and Horwitz,  1993).  Furthermore,  this region of 
the cytoplasmic domain is predicted  to form an c~ helix in 
which  the  aspartic  acid  and  glutamic  acid  residues  lie  in 
close proximity on  one face of the  helix.  To determine  if 
these acidic residues were important in binding pp125 yAK, 
a synthetic peptide similar to SP1 but with alanine residues 
substituted  for the aspartic and glutamic acid residues was 
tested for binding activity. This variant peptide was unable 
to bind to pp125 yAK (Fig. 3 C) or paxillin (data not shown). 
These  results  indicate  that  the  highly  conserved  aspartic 
and glutamic acid residues  are necessary for complex for- 
mation  with  pp125 yAK, either  by  providing  a  negatively 
charged  surface for binding  or by influencing  the  confor- 
mation of the peptide to maintain the integrity of the bind- 
ing site. 
The sites of the 131 peptide to which pp125 yAK and paxil- 
lin bind are virtually coincident,  suggesting that binding of 
one might be dependent  upon the other. This possibility is 
supported  by our observations that pp125 yAK and paxitlin 
can  form  a  physical  complex  both  in  vivo  and  in  vitro 
(Hildebrand et al., 1995). The interdependency of pp125 yAK 
and paxillin in integrin binding was examined by preclear- 
ing one of these proteins  from CE cell lysates and  testing 
for integrin binding activity of the other protein, which re- 
mained  in  the  lysate.  Immunodepletion  of paxillin  from 
cell  lysates  does  not  impair  the  13i  binding  activity  of 
pp125  FAK (Fig. 4 A). Similarly immunodepletion of pp125 FAK 
from CE cell lysates does not reduce  the 131 binding activ- 
ity of paxillin  (Fig. 4  B). Thus the  integrin  binding  activi- 
ties of pp125 FAK and paxillin are independent. 
The site on pp125 FAK to which the 131 peptide  binds was 
explored  using  extracts  containing  a  naturally  occurring 
variant  of pp125 FAK called p41FRNK (the  COOH-terminal 
noncatalytic domain of pp125 FAK expressed from an alter- 
nately processed mRNA  [Schaller et al., t993]) or a  series 
of engineered  variants  bearing  deletions  in  the  NH2-  or 
COOH-terminal  domains  (Hildebrand  et  al.,  1993).  CE 
cells were  transfected  with  replication  competent retrovi- 
ral vectors encoding each construct and upon full infection 
of the  culture,  lysates were prepared  and  incubated  with 
[31-beads.  As above, N10%  of the  pp125 FA~: in  the  lysate 
bound  to  the  131-beads.  In  contrast,  virtually  no  p41FRNr~ 
was retained on the beads (Fig. 5 A). This observation was 
supported  by the  analysis  of pp125 yAK deletion  mutants. 
Deletion  of virtually the entire  COOH-terminal  noncata- 
lytic  domain  (corresponding  to  the  sequences  found  in 
p41FRNK)  did  not  compromise  the  131  binding  activity  of 
pp125 FAK  (Fig.  5  B).  Thus  the  131  binding  site  within 
pp125 yAK does not reside within the COOH-terminal non- 
catalytic domain. 
Since the 131-binding  site was not in the COOH-terminal 
domain,  an in vitro translation  approach was used to gen- 
erate  COOH-terminal  truncations  of pp125 FAK to further 
define  the  131 binding  site of pp125 FAK. An  in vitro trans- 
lated  polypeptide  containing  residues  1-344  bound  very 
efficiently to 131 beads whereas in vitro translated  p41FRNK 
(corresponding  to amino acids 693-1052  of pp125 FaK)  did 
not  bind  to  131  beads  (data  not  shown).  To  further  test 
which domain mediated  binding  of pp125 FAK to 131 beads, 
Figure 4. pp125 yAK and paxil- 
lin bind independently  to  131 
peptide.  CE  cell  lysate  was 
immunodepleted  by  incuba- 
tion  with  an  anti-paxillin 
mAb  or  an  anti-pp125 yAK 
mAb  (2A7).  A  control  im- 
munoprecipitation  was  per- 
formed  using  goat  anti- 
mouse  antibodies  (a-mouse). 
An  aliquot  equal  to  10%  of 
the  total  volume  was  re- 
moved from the depleted su- 
pernatants  as  a  loading 
control  (lysate)  and  the  re- 
mainder  incubated  with  [31 
beads  (131).  Proteins  that 
bound to the beads were de- 
tected  by  Western  blotting 
using  anti-pp125  FAK  rabbit 
serum, BC3 (A) or anti-paxil- 
lin mAb (B). 
Figure 5. pp125 yAK does not bind via its COOH terminus. (A) Ly- 
sates from CE cells overexpressing pp125 FAK (lanes 1 and 2) or 
p41FRNK (lanes 3  and 4) were incubated with  131 beads (lanes 2 
and 4) and the bound proteins analyzed by Western blotting for 
pp125  FAK. Loading controls are in lanes 1 and 3. (B) Lysates from 
CE  cells  expressing  an  epitope-tagged  derivative  of wild  type 
pp125 yAK (lanes 1 and 2) or epitope-tagged d1686-1011  (lanes 3 
and  4)  were  incubated  with  131  beads  (lanes 2  and  4)  and  the 
bound proteins analyzed by blotting with mAb KT3 to detect the 
tag. Loading controls are in lanes 1 and 3. 
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were tested for binding. An NH2-terminal fragment (resi- 
dues  31-376)  and  a  COOH-terminal  fragment  (residues 
765-1052) of FAK were expressed as glutathione-S-trans- 
ferase fusion  proteins  and  purified  on  glutathione  seph- 
arose  beads.  The  fusion proteins  were  labeled  by phos- 
phorylation  with  protein  kinase  A,  which  recognizes  a 
sequence within the linker between the GST and FAK se- 
quences.  The  FAK  polypeptides  were  cleaved from the 
GST  sequences  with  thrombin  and  the  GST  fragments, 
bound to the glutathione beads, and removed by centrifu- 
gation. The 32p-labeled fragments of pp125 FAK were then 
incubated with 131 beads as above. As shown in Fig. 6, the 
NHz-terminal  fragment  of FAK  efficiently bound  to  [31 
beads, whereas the COOH-terminal fragment was incapa- 
ble of binding to the 131 peptide. Furthermore the NH2-ter- 
minal fragment of pp125  zAK efficiently bound  to  SP1  but 
bound very poorly to the control peptide SPIAA (data not 
shown).  These  data  demonstrate  that  pp125  FAK  directly 
binds to  the  131  integrin  cytoplasmic peptide  and  further 
supports the observation that a binding site resides within 
the NH2-terminal, noncatalytic domain. 
Discussion 
Like the integrins, a number of transmembrane receptors 
that are devoid of enzymatic activity trigger the phospho- 
rylation  of  cellular  proteins  on  tyrosine.  In  several  in- 
stances this linkage is accomplished by the physical associ- 
ation of an intracellular  protein tyrosine kinase with the 
cytoplasmic domain of the  receptor. For example, the  T 
cell surface markers CD4 and CD8 are physically associ- 
ated via short cytoplasmic domains to the protein tyrosine 
kinase p56  lck (Sefton, 1991).  Similarly a number of recep- 
tors including the erythropoietin receptor and growth hor- 
mone receptor physically complex with the  protein tyro- 
sine kinase Jak2 (Ihle et al., 1994;  Ziemiecki et al., 1994). 
In each case binding of ligand to the receptor results in the 
activation of the catalytic activity of the associated kinase. 
The studies reported here provide evidence that integrin/ 
pp125 FAK signaling might occur in a similar manner. 
Figure.  6.  pp125 FAK binds di- 
rectly  to  [31  beads,  Glu- 
tathione-S-transferase  fusion 
proteins containing FAK res- 
idues  31-376  (nterm-lanes 1 
and  2)  or  765-1052  (cterm- 
lanes  3  and  4)  were  ex- 
pressed  in  E.  coli, purified 
and  labeled  as  in  Materials 
and  Methods.  Each  was 
tested for its  ability  to bind 
[31 beads (lanes 2 and 4) and 
bound  material analyzed  by 
SDS-PAGE and autoradiog- 
raphy. Loading control (10% 
of  the  material  incubated 
with  the  [31 beads) is shown 
in lanes 1 and 3. 
Using the in vitro binding assay we have established that 
pp125 FAK and the cytoskeletal protein paxillin can associ- 
ate with a synthetic peptide modeled upon the COOH-ter- 
minal, cytoplasmic domain of the [31 integrin. These inter- 
actions are mediated by the membrane proximal region of 
the [31 cytoplasmic domain and two highly conserved, neg- 
atively charged residues which appear to be necessary for 
binding. Two scrambled peptides with an amino acid com- 
position identical to  SP1  were  also tested for binding  to 
pp125  vA~. The scrambled peptides exhibited variable bind- 
ing to pp125  yAK. This is in direct contrast to SP1 which al- 
ways bound  to  pp125  FA~  with  high  efficiency  (data  not 
shown). It is possible that this peptide is too short to be ef- 
fectively scrambled, and that in scrambled form the pep- 
tide still exhibited sufficiently similar properties to SP1  to 
bind  to  pp125  yAK. It  is  unlikely,  however,  that  the  ob- 
served  interaction  is  a  nonspecific  charge  effect  since 
pp125 yAK and  paxillin  bind  poorly to  SP2.  SP1  contains 
three basic and two acidic residues and a sequence of four 
consecutive  charged  amino  acids  (two  positive  and  two 
negative). SP2 contains four basic and two acidic residues 
and  likewise  contains  a  sequence  of  four  consecutive 
charged amino acids (two positive and two negative). De- 
spite their similarity in charge the two peptides exhibit dis- 
tinct binding specificities. Additional evidence for binding 
specificity comes from the analysis of FRNK binding. Al- 
though FRNK has been demonstrated  to mediate exten- 
sive protein-protein interactions  (Hildebrand et al., 1993, 
1995), FRNK failed to bind to either 131- or SPl-peptide- 
containing beads. 
It is interesting  to  note that  there  are  two reports de- 
scribing  mutations  of  one  or  the  other  acidic  residues 
within the SP1 region of the [31 integrin. Variants with le- 
sions at this site exhibit a small decrease in the capacity to 
localize to focal adhesions, but in combination with a sec- 
ond point mutation in the membrane distal portion of the 
13~ cytoplasmic domain exhibits a severe reduction in local- 
ization  to  focal  adhesions  (Reszka  et  at.,  1992).  These 
acidic residues  have  also  been  altered  in  the  [31  integrin 
subunit of Drosophila melanogaster (Grinblat et al., 1993). 
This variant has been substituted for the wild-type allele in 
vivo and the resulting flies exhibit a defect in the normal 
development of the wing. These results implicate this re- 
gion of the integrin as a critical region for the normal func- 
tion of these receptors in the cell. 
Recent  evidence strongly supports the  functional  link- 
age of pp125 yAK to integrins containing the  [31 or 133 sub- 
units  (Guan  and  Shalloway,  1992;  Lipfert  et  al.,  1992). 
Using chimeric receptors containing extracellular and trans- 
membrane sequences from the IL-2-receptor  fused to the cy- 
toplasmic domains  of various integrins  it  has  been  estab- 
lished  that  cross-linking of the  tails of [3  integrin  subunits 
alone is sufficient to induce tyrosine phosphorylation (Aki- 
yama et al., 1994). This analysis has also established that the 
cytoplasmic domains of the [31,133, and [35 integrin subunits 
can trigger tyrosine phosphorylation, but the tail of the [33B 
variant  integrin  subunit  cannot.  Exogenous  expression  of 
human [31 integrin subunits in CHO cells and induction of 
clustering by plating onto immobilized anti-human 131 mono- 
clonal antibodies indicates that the [31B subunit is also unable 
to activate FTKs (Balzac et al., 1994). Comparison of the se- 
quences  of  the  13a, [33, and  [3s  integrin  subunits  reveals 
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divergence in sequence towards the carboxy terminus with 
but a few highly conserved charged residues in this region. 
The sequences for the [31B and 113B integrin subunits diverge 
from the 131 and 133 sequences in the region which is poorly 
conserved between these integrins.  It is therefore possible 
that the few scattered conserved residues in the membrane 
distal region of the cytoplasmic tail of the [3 integrin subunits 
are linked to the signaling apparatus that activates PTKs. Al- 
ternatively, the  highly conserved, membrane proximal se- 
quences of the cytoplasmic domains may regulate the activa- 
tion of PTKs, but the distal sequences may be required for 
some other facet of signaling,  for example tethering the sig- 
naling complex in the proper cellular location to transduce 
the signal. 
The in vitro binding data presented above are consistent 
with a model in which pp125  FAK may be physically associ- 
ated with the cytoplasmic domain of 131 and  113 integrins 
within the  cell.  Evidence supporting  this  hypothesis has 
come from two different experimental approaches. First, 
capping of cell surface integrins can, under certain circum- 
stances, lead to cocapping of many focal adhesion-associ- 
ated proteins. Cross-linking of integrins on human fibro- 
blasts using certain anti-[3t  or anti-a t  antibodies leads to 
specific cocapping of a very limited subset of focal adhe- 
sion-associated proteins including pp125  var~ (Miyamoto et 
al.,  1995).  Secondly, analysis of a series of 113 cytoplasmic 
domain  deletion  variants  revealed  that  the  membrane 
proximal 12 amino acids of the 113 integrin are sufficient to 
trigger aHb113-dependent  phosphorylation of pp125  FAK on 
tyrosine (S. Shattil and M. Ginsberg, personal communica- 
tion). Thus the 133 subunit sequences that are sufficient to 
induce the phosphorylation of pp125  FAK in vivo coincides 
with the pp125FAK-binding  site in vitro. 
Despite the fact that similar integrin sequences are im- 
plicated in binding to both pp125  FA~ and paxillin, and de- 
spite our observation that pp125 yAK and paxillin physically 
associate (Hildebrand et al.,  1995), our data indicate that 
binding of these two cytoskeletal proteins to 111 occurs in- 
dependently. Firstly, pp125  FA~ can bind directly to the [31 
peptide via sequences within its NH~-terminal noncatalytic 
domain. Secondly, variants of pp125 FAn that fail to associ- 
ate with paxillin (e.g., d1686-1011) still exhibit 131 binding 
activity. Thirdly, depletion of paxillin from CE lysates by 
immunoprecipitation does not impair binding of pp125 yAK 
to the [32 peptide. Fourthly, immunodepletion of pp125  yAK 
from CE lysates does not impair binding of paxillin to the 
[3l peptide. Finally, 10-fold overexpression of pp125  vAr~ in 
CE lysates, resulting in a  10-fold increase in the absolute 
amount of pp125  FAK that binds to 11t beads, does not result 
in an increase in the amount of paxillin that binds 11a beads 
(data not shown). Whether paxillin binding to 13t is direct 
or indirect is  presently an  unresolved issue  that will  re- 
quire reconstitution experiments using purified recombi- 
nant paxillin to adequately address. 
Although we have shown complex formation between 
the 11I integrin subunit and pp125  FAK in vitro, this interac- 
tion is unlikely to be a major determinant in directing the 
localization of pp125  FAK to cellular focal adhesions in vivo. 
p41FRNK, the  autonomously  expressed  COOH-terminal 
domain of pp125  yAK, localizes to focal adhesions (Schaller 
et al., 1993) yet fails to bind to 111 beads. Furthermore, sev- 
eral COOH-terminal deletion mutants of pp125  yAK, which 
are defective for focal adhesion localization (Hildebrand 
et  al.,  1993),  bind  efficiently to  the  I11  peptide  in  vitro. 
Therefore it appears that pp125  FAK is targeted to the focal 
adhesion by binding to a protein other than the [32 integrin, 
the identity of which is currently unknown. 
The precise mechanism  by which  FAK  becomes acti- 
vated  by  the  integrin  remains  speculative.  Binding  of 
ligand might induce a conformational change in the cyto- 
plasmic domains of the c~-13 integrin dimer. This conforma- 
tional change could expose the pp125  FAK binding site trig- 
gering complex formation and the activation of pp125  yAK 
by occupancy of its integrin binding site. This model pre- 
dicts that pp125 FAK will always be active when complexed 
with 111 and that the key regulatory event is the formation 
of this complex. Alternatively, pp125  FAK may bind consti- 
tutively to 13 integrin subunits. Ligand induced conforma- 
tional changes in the integrin may in turn induce a confor- 
mational change in pp125 FA~ resulting in its activation. In 
both of these models integrin clustering is not necessary 
for the activation of pp125 ra~. However, integrin cluster- 
ing,  induced by ligand  binding,  could potentially play a 
very important role in the activation of pp125  FA~. Integrin 
clustering may directly cause pp125  FAK clustering, leading 
to the activation of pp125  FAK by a mechanism that is analo- 
gous to the activation of the growth factor receptor protein 
tyrosine  kinases.  These  enzymes  become  activated  by 
ligand-induced  dimerization  and  subsequent  transphos- 
phorylation  (Ullrich  and  Schlessinger,  1990).  Whether 
transphosphorylation  of pp125  FAK will  be  an  important 
facet of its activation remains to be tested. 
Current models of the structure of focal adhesions por- 
tray the integrins as key elements that bind to extracellular 
matrix  and  simultaneously  anchor  a  complex  array  of 
structural proteins of the cytoskeleton. Our observations 
that signaling molecules may also physically associate with 
the integrins suggest that multi-component signaling com- 
plexes may form in parallel to structural complexes at sites 
of integrin  adhesion.  Elucidation  of the  interactions  of 
these signaling molecules with each other and the integrins 
will  be  the  key  to  understanding  signal  transduction 
through the integrins. 
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